标题
The adjuvant treatment of kidney cancer: a multidisciplinary outlook
作者
关键词
-
出版物
Nature Reviews Nephrology
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-03-26
DOI
10.1038/s41581-019-0131-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma
- (2018) Cora N. Sternberg et al. CLINICAL CANCER RESEARCH
- IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC)
- (2018) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial
- (2018) M Gross-Goupil et al. ANNALS OF ONCOLOGY
- Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
- (2017) Axel Bex et al. EUROPEAN UROLOGY
- Pharmacotherapy for treating metastatic clear cell renal cell carcinoma
- (2017) Camillo Porta et al. EXPERT OPINION ON PHARMACOTHERAPY
- Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
- (2017) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Treatment for High-Risk Clear Cell Renal Cancer
- (2017) Naomi B. Haas et al. JAMA Oncology
- Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma
- (2017) Karim Chamie et al. JAMA Oncology
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) B. Escudier et al. ANNALS OF ONCOLOGY
- Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy
- (2016) Emiliano Calvo et al. CANCER TREATMENT REVIEWS
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma
- (2015) François-Xavier Nouhaud et al. ANTI-CANCER DRUGS
- Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms
- (2015) E. C. Zabor et al. Clinical Journal of the American Society of Nephrology
- A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
- (2015) Brian Rini et al. LANCET ONCOLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
- (2014) Samira A. Brooks et al. EUROPEAN UROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)
- (2014) Rodolfo Passalacqua et al. JOURNAL OF IMMUNOTHERAPY
- Radionuclides in Nephrourology, Part 2: Pitfalls and Diagnostic Applications
- (2014) A. T. Taylor JOURNAL OF NUCLEAR MEDICINE
- Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma
- (2014) Peir-Haur Hung et al. MEDICINE
- Risk of chronic kidney disease after cancer nephrectomy
- (2014) Lin Li et al. Nature Reviews Nephrology
- Adjuvant Therapy for Renal Cell Carcinoma: Past, Present, and Future
- (2014) S. K. Pal et al. ONCOLOGIST
- Adjuvant Treatment for Resected Renal Cell Carcinoma: Are All Strategies Equally Negative? Potential Implications for Trial Design With Targeted Agents
- (2013) Francesco Massari et al. Clinical Genitourinary Cancer
- Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: Results of a Phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trial
- (2013) M. Aitchison et al. EUROPEAN JOURNAL OF CANCER
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- Onco-Nephrology: AKI in the Cancer Patient
- (2012) A. Q. Lam et al. Clinical Journal of the American Society of Nephrology
- The VHL/HIF axis in clear cell renal carcinoma
- (2012) Chuan Shen et al. SEMINARS IN CANCER BIOLOGY
- Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction
- (2011) Sachin Gupta et al. ANTI-CANCER DRUGS
- Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology
- (2011) Ferran Algaba et al. JOURNAL OF CLINICAL PATHOLOGY
- Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy
- (2011) A. Cho et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis
- (2009) LaMont J. Barlow et al. BJU INTERNATIONAL
- Prognostic Factors for Chronic Kidney Disease After Curative Surgery in Patients With Small Renal Tumors
- (2009) Hwang Gyun Jeon et al. UROLOGY
- Comparison of the UCLA Integrated Staging System and the Leibovich Score in Survival Prediction for Patients With Nonmetastatic Clear Cell Renal Cell Carcinoma
- (2009) Min-Han Tan et al. UROLOGY
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
- (2008) Christopher Wood et al. LANCET
- Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell Carcinoma
- (2008) Vitaly Margulis et al. UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started